Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials

BACKGROUND: Cardiovascular (CV) safety of one anti-diabetic medication over another remains partially delineated. We sought to assess the comparative effect on CV outcomes among novel anti-diabetic agents. METHODS: This study was registered with the International Prospective Register of Systematic R...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Xiao-dong, He, Xin, Yang, Da-ya, Guo, Yue, He, Jian-gui, Xiao, Hai-peng, Liao, Xin-xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989345/
https://www.ncbi.nlm.nih.gov/pubmed/29871636
http://dx.doi.org/10.1186/s12933-018-0722-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989345/
https://www.ncbi.nlm.nih.gov/pubmed/29871636
http://dx.doi.org/10.1186/s12933-018-0722-z

Ejemplares similares